REFERENCES
- Al-Meshal M. A., Khidr S. H., Bayomi M. A., Al-Angary A. A. Oral administration of liposomes containing cyclosporine: a pharmacokinetic study. International Journal of Pharmaceutics 1998; 168: 163–168, [CSA]
- Alpar O. H., Bamford J. B., Walters V. The in vitro incorporation and release of hydroxocobalamin by liposomes. Int. J. Pharm. 1981; 7: 349–351, [CSA], [CROSSREF]
- Aramaki Y., Tomizawa H., Hara T., Yachi K., Kikuchi H., Tsuchiya S. Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration. Pharm. Res. 1993; 10(8)1228–1231, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bayomi M. A., Al-Angary A. A., Al-Meshal M. A., Al-Dardiri M. M. In vivo evaluation of arteether liposomes. Int. J. Pharm. 1998; 175: 1–7, [CSA], [CROSSREF]
- Berge S. M., Henderson N. L., Frank M. J. Kinetics and mechanism of degradation of cefotaxime sodium in aqueous solution. J. Pharm. Sci. 1983; 72(1)59–63, [PUBMED], [INFOTRIEVE], [CSA]
- Betageri G. V., Jenkins S. A., Parsons D. L. Preparation of Liposomes. Liposome Drug Delivery Systems. Informa UK Ltd, Lancaster, PA 1993; 1–24
- Chandler S. G., Thomas N. W., Illum L. Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology. Pharm. Res. 1994; 11(11)1623–1630, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chen H. M., Langer R. Oral particle delivery: status and future trends. Adv. Drug Del. Rev. 1998; 34(2–3)339–350, [CSA], [CROSSREF]
- Dapergolas G., Neerunjun E. D., Gregoriadis G. Penetration of target areas in the rat by liposome-associated bleomycin, glucose oxidase and insulin. FEBS Lett 1976; 63(2)235–239, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Desai M. P., Labhasetwar V., Amidon G. L., Levy R. J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 1996; 13(12)1838–1845, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ebel J. P. A method for quantifying particle absorption from the small intestine of the mouse. Pharm. Res. 1990; 7(8)848–851, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Edwards G. A., Porter C. J. H., Caliph S. M., Khoo S. M., Charman W. N. Animal models for the study of intestinal lymphatic drug transport. Adv. Drug Deliv. Rev. 2001; 50: 45–60, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Eldridge J. H., Hammond C. J., Meulbroek J. A., Staas J. K., Gilley R. M., Tice T. R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Rel. 1990; 11(1–3)205–214, [CSA], [CROSSREF]
- Florence A. T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 1997; 14(3)259–266, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Frey A., Giannasca K. T., Weltzin R., Giannasca P. J., Reggio H., Lencer W. I., Neutra M. R. Role of glycocalyx in regulating access of micropparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 1996; 184(3)1045–1059, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fukui E., Kurohara H., Kageyu A., Kurasaki Y., Nakayama T., Kimura T. Enhancing effect of medium-chain triglycerides on intestinal absorption of d-alpha-to copherol acetate from lecithin-dispersed preparations in the rat. J. Pharmacobiodyn. 1989; 12(2)80–86, [PUBMED], [INFOTRIEVE], [CSA]
- Granger D. N., Taylor A. E. Permeability of intestinal capillaries to endogenous macromolecules. Am. J. Physiol. 1980; 238: H457, [PUBMED], [INFOTRIEVE], [CSA]
- Gregoriadis G., Florence A. T. Liposomes in drug delivery: Clinical, diagnostic and ophthalmic potential. Dugs 1993; 45: 15–28, [CSA]
- Gupta V. D. Stability of cefotaxime sodium as determined by high-performance liquid chromatography. J. Pharm. Sci. 1984; 73(4)565–567, [PUBMED], [INFOTRIEVE], [CSA]
- Hauss D. J., Fogal S. E., Ficorilli J. V., Price C. A., Roy T., Jayaraj A. A., Keirns J. J. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 1998; 87(2)164–169, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Iwanaga K., Ono S., Narioka K., Morimoto K., Kakemi M., Yamashita S., Nango M., Oku N. Oral delivery of insulin by using surface coating liposomes. Improvement of stability of insulin in GI tract. Int. J. Pharm. 1997; 157: 73–80, [CSA], [CROSSREF]
- Jani P., Halbert G. W., Langridge J., Florence A. T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 1989; 41(12)809–812, [PUBMED], [INFOTRIEVE], [CSA]
- Jani P. U., Florence A. T., McCarthy D. E. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int. J. Pharm. 1992; 84: 245–252, [CSA], [CROSSREF]
- Kaiserlian D., Etchart N. Semin. Immunol. 1999; 11(3)217–224, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kimura T. Transmucosal passage of liposomal drugs. Liposomes As Drug Carriers, G. Gregoriadis. Informa UK Ltd, Chichester 1988; 635–648
- Kirk R. E. Split-plot design-factorial design with block treatment confounding. Experimental Design: Procedures for the Behavioral Sciences. Informa UK Ltd, Pacific Grove, CA 1968; 245–318
- Kisel M. A., Kulik L. N., Tsybovsky I. S., Vlasov A. P., Vorob'yov M. S., Kholodova E. A., Zabarovskaya Z. V. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int. J. Pharm. 2001; 216(1–2)105–114, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kulkarni S. B., Betageri G. V., Singh M. Factors affecting microencapsulation of drugs in liposomes. J. Microencapsulation. 1995; 12(3)229–246, [PUBMED], [INFOTRIEVE], [CSA]
- Kwei G. Y., Novak L. B., Hettrick L. H., Reiss E. R., Fong E. K., Olah T. V., Loper A. E. Lymphatic uptake of MK-386, a sterol 5-reductase inhibitor, from aqueous and lipid formulations. Int. J. Pharm. 1998; 164: 37–44, [CSA], [CROSSREF]
- LeFevre M. E., Olivo R., Vanderhoff J. W., Joel D. D. Accumulation of latex in Peyer's patches and its subsequent appearance in villi and mesenteric lymph nodes. Proc. Soc. Exp. Biol. Med. 1978; 159(2)298–302, [PUBMED], [INFOTRIEVE], [CSA]
- LeFevre M. E., Joel D. D., Schidlovsky G. Retention of ingested latex particles in Peyer's patches of germfree and conventional mice. Proc. Soc. Exp. Biol. Med. 1985; 179(4)522–528, [PUBMED], [INFOTRIEVE], [CSA]
- LeFevre M. E., Joel D. D. Distribution of label after intragastric administration of 7Be-labeled carbon to weanling and aged mice. Pro. Soc. Exp. Biol. Med. 1986; 182(1)112–119, [CSA]
- Ling S. S. N., Yuen K. H., Barker S. A. Simple liquid chromatographic method for the determination of cefotaxime in human and rat plasma. J. Chrom. B. 2003; 783: 297–301, [CSA], [CROSSREF]
- Maincent P., Le Verge R., Sado P., Couvreur P., Devissaguet J. P. Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles. J. Pharm. Sci. 1986; 75(10)955–958, [PUBMED], [INFOTRIEVE], [CSA]
- Matsuno K., Schaffner T., Gerber H. A., Ruchti C., Hess M. W., Cottier H. Uptake by enterocytes and subsequent translocation to internal organs, eg, the thymus, of Percoll microspheres administered per os to suckling mice. J. Reticuloendothel. Soc. 1983; 33(4)263–273, [PUBMED], [INFOTRIEVE], [CSA]
- Maury J., Nicoletti C., Guzzo-Chambraud L., Maroux S. The filamentous brush border glycocalyx, a mucin like marker of enterocyte hyperpolarization. Eur. J. Biochem. 1995; 228(2)323–331, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nagata M., Yotsuyanagi T., Nonomura M., Ikeda K. Coagulation recovery after warfarin-induced hypoprothrombinaemia by oral administration of liposomally associated vitamin K1 to rabbits. J. Pharm. Pharmacol. 1984; 36: 527–533, [PUBMED], [INFOTRIEVE], [CSA]
- Neutra M. R. Current concepts in mucosal immunity. V. Role of M cells in transepithelial transport of antigens and pathogens to the mucosal immune system. Am. J. Physiol. 1998; 274(5 Pt 1)G785–G791, [PUBMED], [INFOTRIEVE], [CSA]
- Noguchi T., Charman W. N. A., Stella V. J. Lymphatic appearance of DDT in thoracic or mesenteric lymph duct cannulated rats. Int. J. Pharm. 1985; 24: 185–192, [CSA], [CROSSREF]
- O'Driscoll C. M. Anatomy and physiology of the lymphatics. Lymphatic Transport of Drugs, W. N. Charman, V. J. Stella. Informa UK Ltd, Boca Raton, FL 1992; 1–36
- O'Hagan D. T. Intestinal translocation of particulates-implications for drug and antigen delivery. Adv. Drug. Deliv. Rev. 1990; 5(3)265–285, [CSA], [CROSSREF]
- O'Hagan D. T., Christy N. M., Davis S. S. Particulates and lymphatic drug delivery. Lymphatic Transport of Drugs, W. N. Charman, V. J. Stella. Informa UK Ltd, Boca Raton, FL 1992; 279–315
- Patel H. M., Tuzel N. S., Stevenson R. W. Intracellular digestion of saturated and unsaturated phospholipid liposomes by mucosal cells. Possible mechanism of transport of liposomally entrapped macromolecules across the isolated vascularly perfused rabbit ileum. Biochim. Biophys. Acta. 1985; 839(1)40–49, [PUBMED], [INFOTRIEVE], [CSA]
- Patton T. F., Gilford P. Effect of various vehicles and vehicle volumes on oral absorption of triamterene in rats. J. Pharm. Sci. 1981; 70(19)1131–1134, [PUBMED], [INFOTRIEVE], [CSA]
- Porter C. J. H., Charman S. A., Charman W. A. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. J. Pharm. Sci. 1996; 85(4)351–356, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Raub T. J., Douglas S. L., Melchior S. W., Charman W. N., Morozowich W. Methodologies for assessing intestinal lymphatic transport. Lymphatic Transport of Drugs, W. N. Charman, V. J. Stella. Informa UK Ltd, Boca Raton, FL 1992; 63–122
- Sanders E., Ashworth C. T. A study of particulate intestinal absorption and hepatocellular uptake. Exp. Cell. Res. 1961; 22: 137–145, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sharma A., Sharma U. S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 1997; 154: 123–140, [CSA], [CROSSREF]
- Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm. Res. 1996; 13(6)896–901, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tomizawa H., Aramaki Y., Fujii Y., Hara T., Suzuki N., Yachi K., Kikuchi H., Tsuchiya S. Uptake of phosphatidylserine liposomes by rat Peyer's patches following intraluminal administration. Pharm. Res. 1993; 10(4)549–552, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ueno M., Nakasaki T., Horikoshi I., Sakuragawa N. Oral administrations of liposomally-entrapped heparin to beagle dogs. Chem. Pharm. Bull. 1982; 30: 2245–2247, [PUBMED], [INFOTRIEVE], [CSA]
- Volkheimer G. Persorption of particles: physiology and pharmacology. Adv. Pharmacol. Chemother. 1977; 14: 163–187, [PUBMED], [INFOTRIEVE], [CSA]
- Wagner J. G. Statistics. Fundamentals of Clinical Pharmacokinetics 1st. Informa UK Ltd, Hamilton, IL 1975; 285–305
- Weiner D. L. Design and analysis of bioavailability studies. Statistics in the Pharmaceutical Industry, C. R. Buncher, J. Y. Tsay. Informa UK Ltd, New York 1981; 205–229
- Weiner N., Chiang C. M. Gastrointestinal uptake of liposomes. Liposomes as Drug Carriers, G. Gregoriadis. Informa UK Ltd, Chichester 1988; 599–608
- Yotsuyanagi T., Nagata M., Ikeda K. Oral administration of vitamin K via liposomes. Liposomes as Drug Carriers, G. Gregoriadis. Informa UK Ltd, Chichester 1988; 621–634